Free Trial

UBS Group Issues Pessimistic Forecast for Ryan Specialty (NYSE:RYAN) Stock Price

Ryan Specialty logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • UBS Group cut Ryan Specialty’s price target from $55 to $52 while maintaining a “buy” rating, implying roughly 14.35% upside from the prior close.
  • Analyst sentiment is mixed: eight firms rate the stock Buy, 10 Hold and one Sell, resulting in a consensus “Hold” rating and an average price target of $52.15.
  • Ryan Specialty’s latest quarterly results modestly beat expectations on earnings, reporting $0.51 per share versus the $0.49 estimate, while institutional investors own 84.82% of the stock.
  • Five stocks to consider instead of Ryan Specialty.

Ryan Specialty (NYSE:RYAN - Get Free Report) had its price target reduced by investment analysts at UBS Group from $55.00 to $52.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has a "buy" rating on the stock. UBS Group's price objective points to a potential upside of 14.35% from the stock's previous close.

A number of other analysts have also weighed in on RYAN. Piper Sandler lowered their target price on Ryan Specialty from $48.00 to $40.00 and set a "neutral" rating for the company in a research note on Tuesday, October 6th. Cantor Fitzgerald upped their price target on shares of Ryan Specialty from $34.00 to $41.00 and gave the stock a "neutral" rating in a research report on Monday, August 3rd. Royal Bank Of Canada decreased their price objective on shares of Ryan Specialty from $55.00 to $52.00 and set an "outperform" rating on the stock in a report on Friday. Barclays raised their price objective on shares of Ryan Specialty from $46.00 to $48.00 and gave the company an "overweight" rating in a research report on Friday, July 31st. Finally, Keefe, Bruyette & Woods raised their price objective on shares of Ryan Specialty from $48.00 to $54.00 and gave the company an "outperform" rating in a research report on Friday, July 31st. Eight investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $52.15.

View Our Latest Report on RYAN

Ryan Specialty Price Performance

Shares of NYSE:RYAN traded up $1.63 on Monday, hitting $45.47. The stock had a trading volume of 2,434,540 shares, compared to its average volume of 2,200,786. Ryan Specialty has a twelve month low of $29.28 and a twelve month high of $58.94. The company has a debt-to-equity ratio of 4.03, a quick ratio of 1.00 and a current ratio of 1.01. The firm's 50 day moving average price is $40.42 and its 200-day moving average price is $39.17. The company has a market capitalization of $11.63 billion, a price-to-earnings ratio of 56.14, a price-to-earnings-growth ratio of 0.90 and a beta of 0.54.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.02. Ryan Specialty had a net margin of 8.25% and a return on equity of 47.77%. The company had revenue of $789.96 million during the quarter, compared to analyst estimates of $792.99 million. During the same quarter last year, the business posted $0.47 earnings per share. On average, equities research analysts predict that Ryan Specialty will post 2.17 earnings per share for the current year.

Institutional Trading of Ryan Specialty

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vancity Investment Management Ltd bought a new stake in shares of Ryan Specialty in the 2nd quarter valued at $621,000. Guardian Point Capital LP increased its holdings in shares of Ryan Specialty by 15.0% in the first quarter. Guardian Point Capital LP now owns 575,000 shares of the company's stock worth $19,400,000 after acquiring an additional 75,000 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of Ryan Specialty by 34.8% in the first quarter. Bank of America Corp DE now owns 1,508,083 shares of the company's stock worth $50,883,000 after acquiring an additional 389,505 shares in the last quarter. Vulcan Value Partners LLC raised its position in shares of Ryan Specialty by 20.0% during the second quarter. Vulcan Value Partners LLC now owns 7,912,669 shares of the company's stock worth $298,782,000 after purchasing an additional 1,317,334 shares during the period. Finally, Confluence Investment Management LLC lifted its holdings in shares of Ryan Specialty by 64.6% during the 3rd quarter. Confluence Investment Management LLC now owns 311,140 shares of the company's stock valued at $11,512,000 after purchasing an additional 122,139 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.

Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.

Recommended Stories

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines